Exploring the future of CSR subsidies

The potential nonpayment of cost-sharing reduction (CSR) subsidies to health insurers could create instability in the Affordable Care Act’s individual market. Issuers are now contemplating their exchange participation plans for 2018, and the future of cost-sharing reductions will play a key role in their decision. This report by Milliman’s Pedro Alcocer, Frederick Busch, and Jason Karcher explores the possible legislative and regulatory outcomes and potential issuer responses.

One thought on “Exploring the future of CSR subsidies

Leave a Reply

Your email address will not be published. Required fields are marked *